• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多囊卵巢增生症:一种被低估的非肿瘤性高雄激素血症病因。

Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.

机构信息

Department of Gynecological Endocrinology, Poznan University of Medical Sciences, Poznan, Poland.

Appletree Medical Group, Ottawa, Canada.

出版信息

Gynecol Endocrinol. 2021 Aug;37(8):677-682. doi: 10.1080/09513590.2021.1903419. Epub 2021 Mar 24.

DOI:10.1080/09513590.2021.1903419
PMID:33759685
Abstract

Hyperthecosis is defined as the presence of nests of luteinized theca cells in the ovarian stroma. Persistent testosterone released by ovarian theca cells is unmasked postmenopausally through the loss of granulosa cell-mediated aromatization of testosterone to estradiol. Ovarian hyperthecosis (OH) usually presents with symptoms of hyperandrogenism and is often described as a severe or extreme form of Polycystic Ovary Syndrome (PCOS). Serum testosterone levels in excess of 150 ng/dl (>5.2 nmol/l) are seen in affected patients and this threshold is used to confirm a diagnosis. Treatment of hyperthecosis is multi-faceted. It addresses the attendant hyperandrogenism (hirsutism and virilization) as well as metabolic complications such as obesity and insulin resistance. Ultimately, laparoscopic bilateral salpingo-oophorectomy is definitive treatment. This remains the treatment of choice in postmenopausal women whereas treatment using GnRH agonists may be used in women of reproductive age, especially younger women. Nevertheless, if serum testosterone remains elevated despite several months of therapy with a GnRH agonist, surgery is often required for biopsy sample collection and further definitive therapy. In order to mitigate the common clinical manifestations of hyperandrogenism, anti-androgen therapy (either cyproterone acetate or spironolactone) may be used to suppress the actions of testosterone on tissues. In patients with impaired glucose metabolism and insulin resistance, Metformin should also be considered as part of treatment. Combined, such a treatment regimen will often lead to decreased ovarian androgen secretion.

摘要

卵巢间质细胞黄素化滤泡膜细胞瘤是指卵巢间质中存在黄素化滤泡膜细胞巢。绝经后,卵巢滤泡膜细胞持续释放的睾酮,通过失去颗粒细胞介导的睾酮向雌二醇的芳香化作用而显现出来。卵巢间质细胞增生症(OH)通常表现为高雄激素血症的症状,常被描述为多囊卵巢综合征(PCOS)的严重或极端形式。受影响的患者血清睾酮水平超过 150ng/dl(>5.2nmol/l),该阈值用于确认诊断。卵巢间质细胞增生症的治疗是多方面的。它针对伴随的高雄激素血症(多毛症和男性化)以及代谢并发症,如肥胖和胰岛素抵抗。最终,腹腔镜双侧输卵管卵巢切除术是明确的治疗方法。这仍然是绝经后妇女的治疗选择,而生殖年龄妇女(尤其是年轻妇女)可使用 GnRH 激动剂治疗。然而,如果血清睾酮在 GnRH 激动剂治疗数月后仍升高,通常需要手术采集活检样本进行进一步明确的治疗。为了减轻高雄激素血症的常见临床表现,可以使用抗雄激素治疗(醋酸环丙孕酮或螺内酯)来抑制睾酮对组织的作用。对于葡萄糖代谢受损和胰岛素抵抗的患者,也应考虑将二甲双胍作为治疗的一部分。联合使用时,这种治疗方案通常会导致卵巢雄激素分泌减少。

相似文献

1
Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism.多囊卵巢增生症:一种被低估的非肿瘤性高雄激素血症病因。
Gynecol Endocrinol. 2021 Aug;37(8):677-682. doi: 10.1080/09513590.2021.1903419. Epub 2021 Mar 24.
2
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.绝经后女性高雄激素血症的研究方法。
J Clin Endocrinol Metab. 2023 Apr 13;108(5):1243-1253. doi: 10.1210/clinem/dgac673.
3
Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.一名患有促性腺激素依赖性卵巢卵泡膜细胞增生症的女性出现绝经后男性化。
J Endocrinol Invest. 1998 Feb;21(2):128-32. doi: 10.1007/BF03350327.
4
[Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].[多囊卵巢综合征患者的支持-间质细胞瘤(男性细胞瘤):临床、超声、激素及组织病理学评估]
Srp Arh Celok Lek. 2001 May-Jun;129 Suppl 1:51-5.
5
Postmenopausal hyperandrogenism.绝经后高雄激素血症。
Climacteric. 2022 Apr;25(2):109-117. doi: 10.1080/13697137.2021.1915273. Epub 2021 May 14.
6
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.美国临床内分泌医师协会、美国内分泌学会以及雄激素过多与多囊卵巢综合征协会疾病状态临床综述:多囊卵巢综合征评估与治疗最佳实践指南——第1部分。
Endocr Pract. 2015 Nov;21(11):1291-300. doi: 10.4158/EP15748.DSC.
7
Severe hyperandrogenemia in postmenopausal woman as a presentation of ovarian hyperthecosis. Case report and mini review of the literature.绝经后女性严重高雄激素血症表现为卵巢卵泡膜细胞增生症。病例报告及文献综述
Gynecol Endocrinol. 2017 Nov;33(11):836-839. doi: 10.1080/09513590.2017.1337094. Epub 2017 Jun 11.
8
Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.绝经后妇女的卵巢睾丸间质细胞瘤和卵巢卵泡膜细胞瘤:病例报告及文献复习。
Medicina (Kaunas). 2023 Jun 6;59(6):1097. doi: 10.3390/medicina59061097.
9
Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.临床病例研讨会:绝经后雄激素过多症-卵巢性索间质肿瘤的诊断和治疗挑战。
Clin Endocrinol (Oxf). 2018 Jan;88(1):13-20. doi: 10.1111/cen.13492. Epub 2017 Nov 7.
10
A rare case of postmenopausal hyperandrogenism due to ovarian hyperthecosis and hilus cell hyperplasia.一例罕见的绝经后高雄激素血症,由卵巢性索间质增生症和门细胞增生引起。
Post Reprod Health. 2022 Mar;28(1):51-55. doi: 10.1177/20533691211073451. Epub 2022 Feb 10.

引用本文的文献

1
Ovarian Hyperthecosis Presenting as Polycythemia.表现为红细胞增多症的卵巢泡膜细胞增生症
AACE Clin Case Rep. 2024 Dec 2;11(2):89-92. doi: 10.1016/j.aace.2024.11.008. eCollection 2025 Mar-Apr.
2
Unusual Presentation of Hyperandrogenism in Postmenopausal Women: A Report of Two Patients With Leydig Cell Hyperplasia.绝经后女性高雄激素血症的不寻常表现:两例莱迪希细胞增生患者的报告
Cureus. 2024 Dec 13;16(12):e75640. doi: 10.7759/cureus.75640. eCollection 2024 Dec.
3
Polycystic ovarian syndrome (PCOS) and recurrent spontaneous abortion (RSA) are associated with the PI3K-AKT pathway activation.
多囊卵巢综合征(PCOS)和复发性自然流产(RSA)与 PI3K-AKT 通路的激活有关。
PeerJ. 2024 Sep 6;12:e17950. doi: 10.7717/peerj.17950. eCollection 2024.
4
Ovarian Hyperthecosis in a 12-year-old Chinese Girl Presenting With Virilization.一名12岁中国女孩出现男性化表现的卵巢卵泡膜细胞增生症。
JCEM Case Rep. 2023 Dec 15;2(1):luad140. doi: 10.1210/jcemcr/luad140. eCollection 2024 Jan.
5
Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women-What Is the Evidence?高雄激素血症与绝经前后妇女的心血代谢风险——有何证据?
J Clin Endocrinol Metab. 2024 Apr 19;109(5):1202-1213. doi: 10.1210/clinem/dgad590.
6
A Rare Case of Hyperandrogenism Due to Fibrothecoma and Leydig Cell Tumor in a Postmenopausal Woman With Adrenal Adenoma: A Case Report and Literature Review.一名绝经后女性肾上腺腺瘤合并纤维卵泡膜瘤和睾丸间质细胞瘤导致高雄激素血症的罕见病例:病例报告及文献综述
Cureus. 2023 Aug 9;15(8):e43180. doi: 10.7759/cureus.43180. eCollection 2023 Aug.
7
Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.绝经后妇女的卵巢睾丸间质细胞瘤和卵巢卵泡膜细胞瘤:病例报告及文献复习。
Medicina (Kaunas). 2023 Jun 6;59(6):1097. doi: 10.3390/medicina59061097.
8
Surgical treatment of post-menopausal ovarian hyperandrogenism improves glucometabolic profile alongside clinical hirsutism.绝经后卵巢雄激素过多症的手术治疗可改善糖代谢状况及临床多毛症状。
SAGE Open Med Case Rep. 2023 Jun 5;11:2050313X231178404. doi: 10.1177/2050313X231178404. eCollection 2023.
9
[Not Available].[无可用内容]
CMAJ. 2023 Apr 24;195(16):E595-E597. doi: 10.1503/cmaj.220685-f.
10
PCOS in Adolescents-Ongoing Riddles in Diagnosis and Treatment.青少年多囊卵巢综合征——诊断与治疗中仍未解开的谜团
J Clin Med. 2023 Feb 3;12(3):1221. doi: 10.3390/jcm12031221.